Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew navigation and help sections were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The old header text (Intervention / Treatment) was replaced by the new Intervention/Treatment heading and the previous Revision notice (Revision: v3.5.5) was removed in favor of Revision: v3.6.0.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site’s revision label changes from v3.5.4 to v3.5.5, indicating a new deployment; user-facing content and the listed study information remain the same.SummaryDifference0.0%

- Check38 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added, replacing the previous 'Revision: v3.5.3'. This indicates an update to the page's revision history rather than a change to visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-content site release or build change rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedPadua, Italy was updated to Padova, Italy in the locations section.SummaryDifference0.0%

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.